RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,337,123 | +4.2% | 407,290 | -25.0% | 0.03% | -6.5% |
| Q2 2023 | $8,957,533 | -24.4% | 543,210 | -18.2% | 0.03% | -26.2% |
| Q1 2023 | $11,846,224 | +87662.8% | 664,026 | +43.3% | 0.04% | -14.3% |
| Q4 2022 | $13,498 | -99.9% | 463,516 | -1.5% | 0.05% | +11.4% |
| Q3 2022 | $11,525,000 | +302.7% | 470,410 | -31.8% | 0.04% | +300.0% |
| Q2 2022 | $2,862,000 | -64.8% | 689,720 | -2.3% | 0.01% | -52.2% |
| Q1 2022 | $8,132,000 | +19.0% | 705,920 | +3.1% | 0.02% | +15.0% |
| Q4 2021 | $6,834,000 | +4.2% | 684,746 | +36.3% | 0.02% | -4.8% |
| Q3 2021 | $6,560,000 | +135.1% | 502,270 | +252.5% | 0.02% | +133.3% |
| Q2 2021 | $2,790,000 | – | 142,472 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |